Skip to main content

Table 6 3D STE derived LA function parameters in subjects with normal LA size (defined as 2DLAVImax ≤34 ml/m2)

From: Left atrial morpho-functional remodeling in atrial fibrillation assessed by three dimensional speckle tracking echocardiography and its value in atrial fibrillation screening

Parameters

Control

PAF

Per-AF

p

n = 55

n = 113

n = 37

LAVmin(ml)

19 (15,24)

28 (22,34)*

45 (40,48)*†

<0.001

LAVmax(ml)

41 (34,49)

49 (43,57)*

61 (54,66)*†

<0.001

LAVpreA(ml)

31 (26,37)

39 (34,46)*

/

<0.001

LAVImax(ml/m2)

24.7 (19.7,27.8)

28.1 (23.7,31.5)*

31.6 (27.2,36.1)*†

<0.001

LAEV(ml)

21 (17,25)

21 (16,26)

16 (11,18)*†

<0.001

LAEF(%)

54 (48,58)

43 (37,49)*

24 (19,29)*†

<0.001

pLAEF(%)

24 (20,28)

20 (15,24)*

24 (19,29)†

<0.001

aLAEF(%)

40 (35,44)

27 (21,36)*

/

<0.001

LASr(%)

21 (18,26)

16 (13,20)*

8 (6,11)*†

<0.001

LAScd(%)

−10(−13,−7)

−8(−10,−6)*

−8(−11,−6)*

0.007

LASct(%)

−11(−14,−9)

−7(− 10,−4)*

/

<0.001

LASrc(%)

31 (26,36)

19 (14,25)*

8 (6,11)*†

<0.001

LAScdc(%)

−11(− 14,−7)

−7(− 11,−5)*

−8(− 11,−6)*

<0.001

LASctc(%)

−20(−24,−15)

−12(−18,−7)*

/

<0.001

  1. *p after Bonferroni’s correction < 0.05 versus control group
  2. †p after Bonferroni’s correction < 0.05 versus PAF group